U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 50 points on Thursday. Shares of Leslie’s, Inc. (NASDAQ:LESL) fell sharply in today's pre-market trading after the company issued preliminary third-quarter financial results below estimates and cut its FY24 guidance. After the market close on Wednesday, Leslie's announced it now expects third-quarter revenue of approximately $570 million versus estimates of $615.407 million. The pool supply company anticipates third-quarter adjusted earnings of 32 cents to 33 cents per share versus Benzinga Pro estimates of 42 cents per share. Leslie's also cut its full-year 2024 revenue guidance from a range of $1.14

Analysts' ratings for Agilon Health (NYSE:AGL) over the last quarter vary from bullish to bearish, as provided by 6 analysts. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 0 6 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 2 0 0 3M Ago 0 0 3 0 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $6.48, with a high estimate of $7.00 and a low estimate of $6.00. Highlighting a 5.4% decrease, the current average has fallen from the pr

Evercore ISI Group analyst Elizabeth Anderson maintains Agilon Health (NYSE:AGL) with a In-Line and raises the price target from $5.5 to $7.

U.S. stocks were mixed, with the Dow Jones index falling more than 100 points on Wednesday. Shares of Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ:OLLI) rose sharply during Wednesday's session following better-than-expected first-quarter earnings. The company reported first-quarter FY24 sales growth of 10.8% year-on-year to $508.82 million, beating the analyst consensus estimate of $505.79 million. Adjusted EPS of 73 cents beat the analyst consensus estimate of 65 cents, according to data from Benzinga Pro. Ollie's raised FY24 adjusted EPS outlook from $3.10 – $3.20 to $3.18 – $3.28, against the consensus of $3.19. The company raised FY24 sales outlook from $2.248 billion – $2.273

agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Jeff Schwaneke, an experienced finance, operational and managed care executive and director on agilon's board, will join the Company as chief financial officer and executive vice president effective July 1, 2024. He will be a member of agilon's Executive Leadership team reporting to chief executive officer (CEO), Steve Sell. Schwaneke succeeds Timothy Bensley, who announced his retirement from agilon in early 2024. Bensley has agreed to stay on through a transition period.

Baird analyst Michael Halloran initiates coverage on Agilon Health (NYSE:AGL) with a Neutral rating and announces Price Target of $6.

During the last three months, 9 analysts shared their evaluations of Agilon Health (NYSE:AGL), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 6 1 0 Last 30D 0 0 1 0 0 1M Ago 0 0 1 0 0 2M Ago 0 0 1 0 0 3M Ago 1 1 3 1 0 In the assessment of 12-month price targets, analysts unveil insights for Agilon Health, presenting an average target of $6.83, a high estimate of $9.00, and a low estimate of $5.00. Observing a downward trend,

Truist Securities analyst Jailendra Singh maintains Agilon Health (NYSE:AGL) with a Hold and raises the price target from $6.4 to $6.5.

Dr. Rao to Continue to Lead Clinical Strategy and Drive Physician Network Performance Alongside agilon's Chief Clinical Officer Kevin Spencer, M.D. agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that after a comprehensive search Karthik Rao, M.D., who has served as agilon's interim chief medical officer (CMO) since February 2024, has been appointed to the permanent CMO role, effective immediately. He previously served as senior medical director and vice president, network performance, at the company. Prior to joining agilon in 2022, Dr. Rao held several roles in value-based care, including nearly a d

agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Jeff Schwaneke, an experienced finance, operational and managed care executive and director on agilon's board, will join the Company as chief financial officer and executive vice president effective July 1, 2024. He will be a member of agilon's Executive Leadership team reporting to chief executive officer (CEO), Steve Sell. Schwaneke succeeds Timothy Bensley, who announced his retirement from agilon in early 2024. Bensley has agreed to stay on through a transition period. Schwaneke was most recently executive vice president, Health Care Enterprises,

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises agilon health, inc. (NYSE:AGL) investors that a lawsuit was filed on behalf of investors that purchased agilon securities between April 15, 2021 and February 27, 2024, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to

Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises agilon health, inc. (NYSE:AGL). investors that a lawsuit was filed on behalf of investors that purchased agilon securities between April 15, 2021 and February 27, 2024, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recov

agilon's latest long-term partnerships with leading multi-specialty and independent primary care practices will expand the delivery of value-based care to more seniors and new communities More than 3,000 primary care doctors are now part of agilon's growing Physician Network agilon health (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it has formed long-term partnerships with five new physician practices across the U.S. to enable their transition to a full-risk, value-based care model. Recognized leaders in their respective communities, the new partners include Graves Gilbert Clinic in Kentucky, Mankato Clinic in M

LOS ANGELES, May 02, 2024 (GLOBE NEWSWIRE) -- Investors can contact the law firm at no cost to learn more about recovering their losses The Portnoy Law Firm advises agilon health, inc. (NYSE:AGL). investors that a lawsuit was filed on behalf of investors that purchased agilon securities between April 15, 2021 and February 27, 2024, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recove

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 01, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises agilon health, inc. (NYSE:AGL). investors that a lawsuit was filed on behalf of investors that purchased agilon securities between April 15, 2021 and February 27, 2024, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recove

agilon health, Inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that Timothy Bensley has informed the company of his intent to retire from his position as Chief Financial Officer (CFO) during 2024, which agilon expects to take place within the next nine months. The search for a new CFO has been initiated, and Bensley has agreed to remain as CFO through this process and serve in a consulting role through the transition. "I want to thank Tim for his leadership over the past three years at agilon health, and for the impact he has had on our company, our physician partners, and the communities we serve," said Steve Sell, c

Zamore brings extensive legal expertise to agilon within the provider and health plan sectors agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced the appointment of Denise Zamore as the company's first Chief Legal Officer and Secretary to the agilon health Board of Directors effective August 1, 2022. Zamore will become a member of the executive leadership team, reporting to Steve Sell, CEO, and will lead the company's legal function. "By creating a chief legal officer position on our executive leadership team, we are taking a significant step to support our continued, rapid growth as an organization," said Steve

Heidi Hittner and Claire Mulhearn to serve as Chief Experience Officer and Chief Communications and Public Affairs Officer, respectively agilon health, inc. (NYSE:AGL), the company transforming health care for seniors by empowering primary-care physicians to focus on the entire health of their patients, announced the appointment of Heidi Hittner and Claire Mulhearn as Chief Experience Officer and Chief Communications and Public Affairs Officer, respectively. Both Hittner and Mulhearn will become members of agilon health's Executive Leadership team, reporting to Steve Sell, Chief Executive Officer. In their new roles, Hittner will be responsible for the company's in-market organic growth s

4 - agilon health, inc. (0001831097) (Issuer)

4 - agilon health, inc. (0001831097) (Issuer)

4 - agilon health, inc. (0001831097) (Issuer)

4 - agilon health, inc. (0001831097) (Issuer)

4 - agilon health, inc. (0001831097) (Issuer)

4 - agilon health, inc. (0001831097) (Issuer)

4 - agilon health, inc. (0001831097) (Issuer)

SC 13G/A - agilon health, inc. (0001831097) (Subject)

SC 13G/A - agilon health, inc. (0001831097) (Subject)

SC 13G/A - agilon health, inc. (0001831097) (Subject)

SC 13G/A - agilon health, inc. (0001831097) (Subject)

SC 13G - agilon health, inc. (0001831097) (Subject)

SC 13G/A - agilon health, inc. (0001831097) (Subject)

SC 13G/A - agilon health, inc. (0001831097) (Subject)

SC 13G/A - agilon health, inc. (0001831097) (Subject)

SC 13G/A - agilon health, inc. (0001831097) (Subject)

SC 13G/A - agilon health, inc. (0001831097) (Subject)

8-K - agilon health, inc. (0001831097) (Filer)

10-Q - agilon health, inc. (0001831097) (Filer)

8-K - agilon health, inc. (0001831097) (Filer)

10-Q - agilon health, inc. (0001831097) (Filer)

8-K - agilon health, inc. (0001831097) (Filer)

8-K - agilon health, inc. (0001831097) (Filer)

8-K - agilon health, inc. (0001831097) (Filer)

10-Q - agilon health, inc. (0001831097) (Filer)

8-K - agilon health, inc. (0001831097) (Filer)

ARS - agilon health, inc. (0001831097) (Filer)

4 - agilon health, inc. (0001831097) (Issuer)

4 - agilon health, inc. (0001831097) (Issuer)

4 - agilon health, inc. (0001831097) (Issuer)

4 - agilon health, inc. (0001831097) (Issuer)

4 - agilon health, inc. (0001831097) (Issuer)

4 - agilon health, inc. (0001831097) (Issuer)

4 - agilon health, inc. (0001831097) (Issuer)

4 - agilon health, inc. (0001831097) (Issuer)

4 - agilon health, inc. (0001831097) (Issuer)

4 - agilon health, inc. (0001831097) (Issuer)

Revenue increased 28% to $1.45 billion, Medicare Advantage membership increased 37% to 525,000, and total members on the agilon platform grew 39% to 657,000 Third quarter results were affected by lower-than-expected 2024 risk adjustment, negative prior year development mainly from risk adjustment and Part D, and higher current year medical expenses Adjusted full year guidance reflects Q3 results and updated Q4 cost trends agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the third quarter ended September 30, 2024. "Our full-risk model enables primary care physicians to deliver high-quality c

agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the third quarter 2024 after the market closes on Thursday, November 7, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international participants and referencing participant code 520026. A simultaneous webcast can be accessed by visiting the "Events & Presentations" section of agilon's Investor Relations website at https://investors.agilonhealth.com. A replay of

Revenue increased 39% to $1.5 billion, Medicare Advantage membership increased 38% to 513,000, and total members on the agilon platform grew 40% to 645,000 Executing targeted action plan and prioritizing profitability First half results reflect retroactive membership adjustments to January 1, 2024 related to agilon's termination of select contracts Maintains 2024 Medical Margin and Adjusted EBITDA Guidance agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the second quarter ended June 30, 2024. "Our second quarter results were in-line with our guidance, and we are maintaining medical margin

agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2024 after the market closes on Tuesday, August 6, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international participants and referencing participant code 689044. A simultaneous webcast can be accessed by visiting the "Events & Presentations" section of agilon's Investor Relations website at https://investors.agilonhealth.com. A replay of t

Revenue increased 52% to $1.6 billion, Medicare Advantage membership increased 43% to 523,000, and total members on the agilon platform grew to 654,000 Continued progress executing performance action plan with focus on driving profitability and enhancing operating efficiency Maintaining full year 2024 guidance for Medical Margin and Adjusted EBITDA agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the first quarter ended March 31, 2024. "Our first quarter results were in-line with our guidance," said Steve Sell, chief executive officer. "We continue to make tangible progress executing our perf

agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2024 after the market closes on Tuesday, May 7, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (929) 526-1599 for international participants and referencing participant code 690899. A simultaneous webcast can be accessed by visiting the "Events & Presentations" section of agilon's Investor Relations website at https://investors.agilonhealth.com. A replay of the c

Revenue increased 72% to $1.06 billion in the fourth quarter 2023, Medicare Advantage membership increased 68% to 388,400, and total members on the agilon platform grew to 477,700 as of December 31, 2023 2023 performance impacted by acceleration in medical costs due to macro dynamics, revised 2024 guidance assumes continuation of higher medical cost trends Executing targeted action plan with focus on measured growth, Class of 2025 expected to add at least 60,000 Medicare Advantage members across 5 physician groups agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the fourth quarter and fiscal ye

agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the fourth quarter and full year 2023 after the market closes on Tuesday, February 27, 2023, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (929) 526-1599 for international participants and referencing participant code 615568. A simultaneous webcast can be accessed by visiting the "Events & Presentations" section of agilon's Investor Relations website at https://investors.agilonhealth.c

Revised 2023 expectations and early outlook for 2024 reflect higher medical and non-medical costs Company is taking targeted actions to improve visibility, balance risk-sharing, and improve predictability of results in 2024 and over the long term agilon health to host conference call at 8:00 AM Eastern Time today agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced revised guidance expectations for 2023, reflecting higher-than-expected costs, and provided an initial outlook for 2024. During 2023, agilon health experienced an increase in medical expenses attributable to higher-than-expected specialist visits,

Revenue increased 75% to $1.22 billion, Medicare Advantage membership increased 58% to 420,300, and total members live on the agilon platform grew to 508,000 Strong performance across core partner markets supported by membership growth and profitability gains in Medicare Advantage and ACO REACH Sale of MDX Hawaii enables agilon to focus on its core partner markets agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the third quarter ended September 30, 2023. "Momentum across our business remains strong, driven by the power of agilon's physician network and platform to improve patient outcomes ac

Revenue increased 28% to $1.45 billion, Medicare Advantage membership increased 37% to 525,000, and total members on the agilon platform grew 39% to 657,000 Third quarter results were affected by lower-than-expected 2024 risk adjustment, negative prior year development mainly from risk adjustment and Part D, and higher current year medical expenses Adjusted full year guidance reflects Q3 results and updated Q4 cost trends agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the third quarter ended September 30, 2024. "Our full-risk model enables primary care physicians to deliver high-quality c

agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the third quarter 2024 after the market closes on Thursday, November 7, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international participants and referencing participant code 520026. A simultaneous webcast can be accessed by visiting the "Events & Presentations" section of agilon's Investor Relations website at https://investors.agilonhealth.com. A replay of

Revenue increased 39% to $1.5 billion, Medicare Advantage membership increased 38% to 513,000, and total members on the agilon platform grew 40% to 645,000 Executing targeted action plan and prioritizing profitability First half results reflect retroactive membership adjustments to January 1, 2024 related to agilon's termination of select contracts Maintains 2024 Medical Margin and Adjusted EBITDA Guidance agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the second quarter ended June 30, 2024. "Our second quarter results were in-line with our guidance, and we are maintaining medical margin

agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2024 after the market closes on Tuesday, August 6, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international participants and referencing participant code 689044. A simultaneous webcast can be accessed by visiting the "Events & Presentations" section of agilon's Investor Relations website at https://investors.agilonhealth.com. A replay of t

Dr. Rao to Continue to Lead Clinical Strategy and Drive Physician Network Performance Alongside agilon's Chief Clinical Officer Kevin Spencer, M.D. agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that after a comprehensive search Karthik Rao, M.D., who has served as agilon's interim chief medical officer (CMO) since February 2024, has been appointed to the permanent CMO role, effective immediately. He previously served as senior medical director and vice president, network performance, at the company. Prior to joining agilon in 2022, Dr. Rao held several roles in value-based care, including nearly a d

agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Jeff Schwaneke, an experienced finance, operational and managed care executive and director on agilon's board, will join the Company as chief financial officer and executive vice president effective July 1, 2024. He will be a member of agilon's Executive Leadership team reporting to chief executive officer (CEO), Steve Sell. Schwaneke succeeds Timothy Bensley, who announced his retirement from agilon in early 2024. Bensley has agreed to stay on through a transition period. Schwaneke was most recently executive vice president, Health Care Enterprises,

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises agilon health, inc. (NYSE:AGL) investors that a lawsuit was filed on behalf of investors that purchased agilon securities between April 15, 2021 and February 27, 2024, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to

Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises agilon health, inc. (NYSE:AGL). investors that a lawsuit was filed on behalf of investors that purchased agilon securities between April 15, 2021 and February 27, 2024, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recov

Revenue increased 52% to $1.6 billion, Medicare Advantage membership increased 43% to 523,000, and total members on the agilon platform grew to 654,000 Continued progress executing performance action plan with focus on driving profitability and enhancing operating efficiency Maintaining full year 2024 guidance for Medical Margin and Adjusted EBITDA agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the first quarter ended March 31, 2024. "Our first quarter results were in-line with our guidance," said Steve Sell, chief executive officer. "We continue to make tangible progress executing our perf

agilon's latest long-term partnerships with leading multi-specialty and independent primary care practices will expand the delivery of value-based care to more seniors and new communities More than 3,000 primary care doctors are now part of agilon's growing Physician Network agilon health (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it has formed long-term partnerships with five new physician practices across the U.S. to enable their transition to a full-risk, value-based care model. Recognized leaders in their respective communities, the new partners include Graves Gilbert Clinic in Kentucky, Mankato Clinic in M